BioGaia AB (publ) (OM: BIOG B)
Health Care · Biotechnology · SE
Skr125.80
+0.16% today · +25.2% 1Y
Public summary
A free snapshot of BioGaia AB (publ), with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app BioGaia AB (publ) (OM: BIOG B) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.25B.
Over the last twelve months the share price has gained 25.2%, trading between 96.20 and 136.30.
Tweenvest scores BioGaia AB (publ) across four factors: quality 90/100, value 36/100, growth 52/100, dividend 73/100. Its strongest factor is quality.
BIOG B price history
Key figures
- Market cap
- $1.25B
- Revenue (TTM)
- $165.73M
- P/E
- 32.51
- EPS
- 3.87
- Dividend yield
- 3.19%
- Beta (5Y)
- 0.23
- 52-week high
- Skr136.30
- 52-week low
- Skr96.20
- Avg volume (3M)
- —
- Shares outstanding
- 101.16M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Pacific Shuanglin Bio-pharmacy Co., Ltd.SZSE: 000403 | $1.26B | CN¥8.99 | -0.66% |
| Metis TechBio Co., Ltd.SEHK: 7666 | $1.26B | HK$8.36 | -19.69% |
| Idorsia LtdSWX: IDIA | $1.26B | CHF3.91 | -1.06% |
| Hualan Biological Vaccine Inc.SZSE: 301207 | $1.25B | CN¥14.05 | -1.75% |
| Silence Therapeutics plcNasdaqGM: SLN | $1.23B | $19.83 | +0.15% |
| Taysha Gene Therapies, Inc.NasdaqGS: TSHA | $1.23B | $3.77 | -5.51% |
| Liaoning Chengda Biotechnology Co., Ltd.SHSE: 688739 | $1.23B | CN¥19.94 | -0.35% |
| COMPASS Pathways plcNasdaqGS: CMPS | $1.23B | $8.65 | +6.53% |